{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:59:43Z","timestamp":1791266383415,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":133,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd002744.pub3","type":"reference-entry","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T14:40:31Z","timestamp":1326897631000},"source":"Crossref","is-referenced-by-count":25,"title":["Neuraminidase inhibitors for preventing and treating influenza in children"],"prefix":"10.1002","author":[{"given":"Kay","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Shun-Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Harnden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,18]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD002744.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1086\/656408","article-title":"Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial","volume":"51","author":"Heinonen","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD002744.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00006454-200005000-00005","article-title":"Zanamivir for treatment of symptomatic influenza A and B infection in children 5 to 12 years of age: a randomized controlled trial","volume":"19","author":"Hedrick","year":"2000","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD002744.pub3-BIB3|cit3","unstructured":"US Food and Drug Administration: Center for Drug Evaluation and Research Relenza - current label http:\/\/www.fda.gov\/cder\/news\/relenza\/default.htm (accessed 2003) 2003"},{"key":"10.1002\/14651858.CD002744.pub3-BIB4|cit4","series-title":"39th Interscience Conference on Antimicrobial Agents and Chemotherapy","article-title":"Inhaled zanamivir for preventing transmission of influenza in families","author":"Hayden","year":"1999"},{"issue":"18","key":"10.1002\/14651858.CD002744.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1056\/NEJM200011023431801","article-title":"Inhaled zanamivir for preventing transmission of influenza in families. Zanamivir Family Study Group","volume":"343","author":"Hayden","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002744.pub3-BIB6|cit6","unstructured":"Anonymous 2006 A double-blind, randomised, placebo-controlled, multicenter study in 2 parallel groups, to investigate the efficacy and safety of inhaled zanamivir (10 mg bd via Diskhaler), for 5 days, in children aged 5 to 12 years with symptomatic influenza A and\/or B infection Glaxo Wellcome Clinical Trials Register (http:\/\/www.gsk-clinicalstudyregister.com\/); unpublished (despite citations at the end of the data)"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/345722","article-title":"Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households","volume":"186","author":"Monto","year":"2002","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD002744.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1128\/AAC.01755-09","article-title":"Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection","volume":"54","author":"Sugaya","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2165\/00002018-200326110-00004","article-title":"Safety and pharmacology of oseltamivir in clinical use","volume":"26","author":"Dutkowski","year":"2003","journal-title":"Drug Safety"},{"issue":"4","key":"10.1002\/14651858.CD002744.pub3-BIB10|cit10","first-page":"421","article-title":"Erratum 2001","volume":"20","author":"Erratum","year":"2001","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD002744.pub3-BIB11|cit11","unstructured":"European Medicines Agency European Public Assessment Report: Tamiflu http:\/\/www.emea.eu.int\/humandocs\/Humans\/EPAR\/tamiflu\/tamiflu.htm (accessed 2005) 2005"},{"key":"10.1002\/14651858.CD002744.pub3-BIB12|cit12","series-title":"World Congress on Lung Health, Florence","article-title":"The impact of oseltamivir treatment on upper and lower respiratory tract complications of acute influenza in children","author":"Hayden","year":"2000"},{"issue":"7","key":"10.1002\/14651858.CD002744.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2165\/00044011-200424070-00003","article-title":"Effect of influenza treatment with oseltamivir on health outcome and costs in otherwise healthy children","volume":"24","author":"Reisinger","year":"2004","journal-title":"Clinical Drug Investigation"},{"issue":"S1","key":"10.1002\/14651858.CD002744.pub3-BIB14|cit14","first-page":"250","article-title":"Oral oseltamivir is eective [sic] and safe in the treatment of children with acute influenza","volume":"6","author":"Reisinger","year":"2000","journal-title":"Clinical Microbiology and Infection"},{"key":"10.1002\/14651858.CD002744.pub3-BIB15|cit15","series-title":"10th European Congress of Clinical Microbiology and Infectious Diseases, Stockholm","article-title":"Oral oseltamivir is effective and safe in the treatment of children with acute influenza","author":"Reisinger","year":"2000"},{"key":"10.1002\/14651858.CD002744.pub3-BIB16|cit16","unstructured":"US Food and Drug Administration: Center for Drug Evaluation and Research Tamiflu - current label http:\/\/www.fda.gov\/cder\/drug\/infopage\/tamiflu\/default.htm (accessed 2004) 2004"},{"key":"10.1002\/14651858.CD002744.pub3-BIB17|cit17","series-title":"9th International Congress on Infectious Diseases, Buenos Aires","article-title":"Safety and acceptability of oseltamivir liquid formulation in the treatment of influenza in children aged 1 to 12 years","author":"Whitley","year":"2000"},{"key":"10.1002\/14651858.CD002744.pub3-BIB18|cit18","series-title":"World Congress on Lung Health, Florence","article-title":"Oral oseltamivir is effective and safe in the treatment of influenza virus infections in children","author":"Whitley","year":"2000"},{"issue":"2","key":"10.1002\/14651858.CD002744.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","article-title":"Oral oseltamivir treatment of influenza in children","volume":"20","author":"Whitley","year":"2001","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"6","key":"10.1002\/14651858.CD002744.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ijporl.2010.03.024","article-title":"Impact of oseltamivir treatment on the incidence and course of acute otitis media in children with influenza","volume":"74","author":"Winther","year":"2010","journal-title":"International Journal of Pediatric Otorhinolaryngology"},{"key":"10.1002\/14651858.CD002744.pub3-BIB21|cit21","series-title":"40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto","article-title":"Oral oseltamivir reduces the risk of developing acute otitis media following influenza infection in children","author":"Winther","year":"2000"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2165\/00002018-200326110-00004","article-title":"Safety and pharmacology of oseltamivir in clinical use","volume":"26","author":"Dutkowski","year":"2003","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD002744.pub3-BIB23|cit23","unstructured":"European Medicines Agency European public assessment report: Tamiflu http:\/\/www.emea.eu.int\/humandocs\/Humans\/EPAR\/tamiflu\/tamiflu.htm (accessed 2005) 2005"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.inf.0000154322.38267.ce","article-title":"Oral oseltamivir improves pulmonary function and reduces exacerbation frequency for influenza-infected children with asthma","volume":"24","author":"Johnston","year":"2005","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD002744.pub3-BIB25|cit25","unstructured":"US Food and Drug Administration: Center for Drug Evaluation and Research Tamiflu: current label http:\/\/www.fda.gov\/cder\/drug\/infopage\/tamiflu\/default.htm (accessed 2004) 2004"},{"key":"10.1002\/14651858.CD002744.pub3-BIB26|cit26","series-title":"9th International Congress on Infectious Diseases, Buenos Aires","article-title":"Safety and acceptability of oseltamivir liquid formulation in the treatment of influenza in children aged 1 to 12 years","author":"Whitley","year":"2000"},{"key":"10.1002\/14651858.CD002744.pub3-BIB27|cit27","series-title":"41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago","article-title":"Effectiveness of oral oseltamivir in preventing spread of influenza-like illness in households with proven influenza","author":"Belshe","year":"2001"},{"key":"10.1002\/14651858.CD002744.pub3-BIB28|cit28","series-title":"42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California","article-title":"Oral oseltamivir prevents the spread of influenza between children in households","author":"Hayden","year":"2002"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1086\/381128","article-title":"Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without post-exposure prophylaxis","volume":"189","author":"Hayden","year":"2004","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD002744.pub3-BIB30|cit30","first-page":"103","article-title":"Oseltamivir prophylaxis during the influenza season in a paediatric cancer centre: prospective observational study","volume":"10","author":"Chik","year":"2004","journal-title":"Hong Kong Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/S0149-2918(02)80082-0","article-title":"The effect of zanamivir treatment on influenza complications:a retrospective cohort study","volume":"24","author":"Cole","year":"2002","journal-title":"Clinical Therapeutics"},{"issue":"24","key":"10.1002\/14651858.CD002744.pub3-BIB32|cit32","first-page":"2132","article-title":"A multicenter study of efficacy and safety of oseltamivir in the treatment of suspected influenza patients","volume":"84","author":"Deng","year":"2004","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"5","key":"10.1002\/14651858.CD002744.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijantimicag.2009.12.023","article-title":"Safety and pharmacokinetics of oseltamivir at standard and high dosages","volume":"35","author":"Dutkowski","year":"2010","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1002\/14651858.CD002744.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1471-2334-10-211","article-title":"Oseltamivir for treatment and prevention of pandemic influenza A\/H1N1 virus infection in households, Milwaukee, 2009","volume":"10","author":"Goldstein","year":"2010","journal-title":"BMC Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD002744.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1086\/314440","article-title":"Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus","volume":"178","author":"Gubareva","year":"1998","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD002744.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1517\/14656566.9.2.151","article-title":"Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children","volume":"9","author":"Gums","year":"2008","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"9","key":"10.1002\/14651858.CD002744.pub3-BIB37|cit37","first-page":"846","article-title":"Appropriate use of rapid diagnostic testing for influenza","volume":"78","author":"Hata","year":"2004","journal-title":"Kansenshogaku Zasshi - Journal of the Japanese Association for Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD002744.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1128\/AAC.00047-08","article-title":"Pharmacokinetics and tolerability of oseltamivir combined with probenecid","volume":"52","author":"Holodniy","year":"2008","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD002744.pub3-BIB39|cit39","first-page":"1664","article-title":"Cost effectiveness analysis of oseltamivir phosphorus in the treatment of influenza","volume":"84","author":"Hu","year":"2004","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub3-BIB40|cit40","first-page":"971","article-title":"The study on efficacy of oseltamivir for influenza A in children","volume":"77","author":"Imamura","year":"2003","journal-title":"Kansenshogaku Zasshi - Journal of the Japanese Association for Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1177\/0091270009356297","article-title":"Clinical pharmacokinetics of laninamivir, a novel long-acting neuraminidase inhibitor, after single and multiple inhaled doses of its prodrug, CS-8958, in healthy male volunteers","volume":"50","author":"Ishizuka","year":"2010","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD002744.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00431-006-0227-8","article-title":"Duration of isolation of children with influenza A treated with oseltamivir","volume":"166","author":"Kano","year":"2007","journal-title":"European Journal of Pediatrics"},{"issue":"12","key":"10.1002\/14651858.CD002744.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.11150\/kansenshogakuzasshi1970.74.1044","article-title":"Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza - placebo-controlled double-blind multicenter phase III trial","volume":"74","author":"Kashiwagi","year":"2000","journal-title":"Kansenshogaku Zasshi"},{"issue":"6","key":"10.1002\/14651858.CD002744.pub3-BIB44|cit44","first-page":"423","article-title":"Effectiveness of oseltamivir on influenza and influencing factors: age of patients, type of influenza virus and timing of initial administration","volume":"77","author":"Kawai","year":"2003","journal-title":"Kansenshogaku Zasshi - Journal of the Japanese Association for Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD002744.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1086\/429241","article-title":"Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season","volume":"40","author":"Kawai","year":"2005","journal-title":"Clinical Infectious Disease"},{"issue":"4","key":"10.1002\/14651858.CD002744.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/505868","article-title":"A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons","volume":"43","author":"Kawai","year":"2006","journal-title":"Clinical Infectious Disease"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jinf.2007.05.176","article-title":"Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir","volume":"55","author":"Kawai","year":"2007","journal-title":"Journal of Infection"},{"issue":"1","key":"10.1002\/14651858.CD002744.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jinf.2007.09.002","article-title":"A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B","volume":"56","author":"Kawai","year":"2008","journal-title":"Journal of Infection"},{"issue":"9436","key":"10.1002\/14651858.CD002744.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1128\/AAC.00474-10","article-title":"Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection","volume":"54","author":"Kohno","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD002744.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.phymed.2006.09.015","article-title":"Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children","volume":"14","author":"Kubo","year":"2007","journal-title":"Phytomedicine"},{"key":"10.1002\/14651858.CD002744.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.clinthera.2007.08.023","article-title":"Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial","volume":"29","author":"LaForce","year":"2007","journal-title":"Clinical Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD002744.pub3-BIB53|cit53","first-page":"455","article-title":"A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population","volume":"27","author":"Lin","year":"2004","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"1","key":"10.1002\/14651858.CD002744.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1185\/030079906X80297","article-title":"A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population","volume":"22","author":"Lin","year":"2006","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD002744.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.bmt.1704534","article-title":"Use of oseltamivir to control influenza complications after bone marrow transplantation","volume":"34","author":"Machado","year":"2004","journal-title":"Bone Marrow Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub3-BIB56|cit56","first-page":"946","article-title":"Effectiveness of oseltamivir treatment against influenza type A and type B infection in children","volume":"76","author":"Mitamura","year":"2002","journal-title":"Kansenshogaku Zasshi - Journal of the Japanese Association for Infectious Diseases"},{"key":"10.1002\/14651858.CD002744.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/135965350400900217","article-title":"Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study","volume":"9","author":"Nordstrom","year":"2004","journal-title":"Antiviral Therapy"},{"key":"10.1002\/14651858.CD002744.pub3-BIB58|cit58","unstructured":"Anonymous 2004 Randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy of oseltamivir in the treatment of influenza-mediated asthma symptoms in pediatric and adolescent patients with asthma Roche Clinical Trial Results Database (www.roche-trials.com) 2004"},{"key":"10.1002\/14651858.CD002744.pub3-BIB59|cit59","unstructured":"Hoffmann-La Roche An open-label, multi-center trial of oseltamivir for the seasonal prophylaxis of influenza in children Roche Clinical Trials"},{"issue":"6","key":"10.1002\/14651858.CD002744.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.inf.0000164799.33635.fe","article-title":"Experience with oseltamivir for infants younger than 1 year old in Japan","volume":"24","author":"Okamoto","year":"2005","journal-title":"Paediatric Infectious Disease Journal"},{"issue":"5-6","key":"10.1002\/14651858.CD002744.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00228-003-0639-6","article-title":"Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 years","volume":"59","author":"Oo","year":"2003","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD002744.pub3-BIB62|cit62","first-page":"131","article-title":"Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005","volume":"10","author":"Peters","year":"2008","journal-title":"Medscape Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD002744.pub3-BIB63|cit63","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/01.inf.0000180976.81055.ce","article-title":"Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors","volume":"24","author":"Sato","year":"2005","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD002744.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1620\/tjem.214.113","article-title":"Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City, Japan","volume":"214","author":"Sato","year":"2008","journal-title":"Tohoku Journal of Experimental Medicine"},{"issue":"Suppl","key":"10.1002\/14651858.CD002744.pub3-BIB65|cit65","first-page":"206","article-title":"A 12-week course of oseltamivir prophylaxis is well tolerated by haematopoietic stem cell transplant recipients","volume":"45","author":"Shapira","year":"2010","journal-title":"Bone Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD002744.pub3-BIB66|cit66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/509925","article-title":"Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children","volume":"44","author":"Sugaya","year":"2007","journal-title":"Clinical Infectious Disease"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/589748","article-title":"Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children","volume":"47","author":"Sugaya","year":"2008","journal-title":"Clinical Infectious Disease"},{"issue":"4","key":"10.1002\/14651858.CD002744.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1442-200x.2005.02088.x","article-title":"Oseltamivir phosphate in infants under 1 year of age with influenza infection","volume":"47","author":"Tamura","year":"2005","journal-title":"Pediatrics International: official journal of the Japan Pediatric Society"},{"key":"10.1002\/14651858.CD002744.pub3-BIB69|cit69","first-page":"528","article-title":"A randomized, double-blinded and controlled clinical evaluation of oseltamivir in the treatment of influenza","volume":"9","author":"Tan","year":"2002","journal-title":"Chinese Journal of Clinical Medicine"},{"key":"10.1002\/14651858.CD002744.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00430-002-0138-x","article-title":"Neuraminidase inhibitors in the management of influenza - experience of an outpatient practice","volume":"191","author":"Vogel","year":"2002","journal-title":"Medical Microbiology and Immunology"},{"key":"10.1002\/14651858.CD002744.pub3-BIB71|cit71","series-title":"16th World Congress of Family Doctors","article-title":"Safety of oseltamivir in clinical use in children and adults","author":"Waskett","year":"2001"},{"issue":"6","key":"10.1002\/14651858.CD002744.pub3-BIB72|cit72","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jama.285.6.748","article-title":"Effectiveness of oseltamivir in preventing influenza in household contacts. A randomized controlled trial","volume":"285","author":"Welliver","year":"2001","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD002744.pub3-BIB73|cit73","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1248\/yakushi.123.887","article-title":"Investigation of the reconsultation rate and pharmacoeconomic evaluation of period of influenza treatment by oseltamivir","volume":"123","author":"Yamaura","year":"2003","journal-title":"Yakugaku Zasshi - Journal of the Pharmaceutical Society of Japan"},{"key":"10.1002\/14651858.CD002744.pub3-BIB74|cit74","unstructured":"High dose versus standard dose oseltamivir for the treatment of severe influenza and avian influenza http:\/\/www.controlled-trials.com\/ISRCTN43083885\/"},{"key":"10.1002\/14651858.CD002744.pub3-BIB75|cit75","unstructured":"High-dose versus standard-dose oseltamivir to treat severe influenza and avian influenza http:\/\/www.controlled-trials.com\/mrct\/trial\/395415\/NCT00298233"},{"key":"10.1002\/14651858.CD002744.pub3-BIB76|cit76","unstructured":"A double-blind, randomised, placebo-controlled, multicenter trial of oseltamivir for the seasonal prophylaxis of influenza in immunocompromised patients http:\/\/www.roche-trials.com\/trialDetailsGet.action?studyNumber=NV20235"},{"key":"10.1002\/14651858.CD002744.pub3-BIB77|cit77","unstructured":"TCAD vs. monotherapy for influenza A in immunocompromised patients http:\/\/www.controlled-trials.com\/mrct\/trial\/497081\/NCT00867139"},{"key":"10.1002\/14651858.CD002744.pub3-BIB78|cit78","unstructured":"A study of Tamiflu (oseltamivir) for treatment of influenza in immunocompromised patients http:\/\/www.roche-trials.com\/trialDetailsGet.action?studyNumber=NV20234"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub3-BIB79|cit79","first-page":"262","article-title":"Effect of post-exposure prophylaxis with oseltamivir for those in contacts with influenza patients in pediatric wards","volume":"78","author":"Shinjoh","year":"2004","journal-title":"Kansenshogaku Zasshi - Journal of the Japanese Association for Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD002744.pub3-BIB80|cit80","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2165\/00003495-199958050-00007","article-title":"Oseltamivir","volume":"58","author":"Bardsley-Elliot","year":"1999","journal-title":"Drugs"},{"issue":"20","key":"10.1002\/14651858.CD002744.pub3-BIB81|cit81","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199805143382002","article-title":"The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children","volume":"338","author":"Belshe","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002744.pub3-BIB82|cit82","unstructured":"BioCryst Pharmaceuticals Inc Announces preliminary phase III trial results for influenza neuraminidase inhibitor, peramivir BioCryst Pharmaceuticals Investor Relations: News. (http:\/\/www.shareholder.com\/biocryst\/news\/20020625-83347.cfm) 2002"},{"issue":"6","key":"10.1002\/14651858.CD002744.pub3-BIB83|cit83","doi-asserted-by":"crossref","first-page":"e1072","DOI":"10.1542\/peds.2008-3074","article-title":"Relative impact of influenza and respiratory syncytial virus in young children","volume":"124","author":"Bourgeois","year":"2009","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD002744.pub3-BIB84|cit84","unstructured":"Brady B McAuley L Shukla VK Economic evaluation of zanamivir for the treatment of influenza. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 2001 Technology Report No. 13 (available from http:\/\/www.ccohta.ca\/) 2001"},{"key":"10.1002\/14651858.CD002744.pub3-BIB85|cit85","unstructured":"National Institute of health and Clinical Excellence Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation Health Technology Assessment 2008"},{"key":"10.1002\/14651858.CD002744.pub3-BIB86|cit86","first-page":"9","article-title":"Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation","volume":"6","author":"Burls","year":"2002","journal-title":"Health Technology Assessment (available from http:\/\/www.hta.nhsweb.nhs.uk)"},{"issue":"7401","key":"10.1002\/14651858.CD002744.pub3-BIB87|cit87","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/bmj.326.7401.1235","article-title":"Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials","volume":"326","author":"Cooper","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002744.pub3-BIB88|cit88","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJMoa044307","article-title":"Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma","volume":"352","author":"Jong","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002744.pub3-BIB89|cit89","unstructured":"Department of Health Immunisation against infectious disease - 'The Green Book' 2006 document Chapter 19 Influenza - updated January 2011 Copyright holder: Crown"},{"key":"10.1002\/14651858.CD002744.pub3-BIB90|cit90","unstructured":"European Medicines Agency Updated review of influenza antiviral medicinal products for potential use during pandemic by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2009\/11\/WC500011117.pdf"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD002744.pub3-BIB91|cit91","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/INF.0b013e31818a542b","article-title":"The global state of influenza in children","volume":"27","author":"Esposito","year":"2008","journal-title":"Paediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD002744.pub3-BIB92|cit92","unstructured":"US Food Drug Administration MedWatch Safety alerts for human medical products: Tamiflu (oseltamivir phosphate) http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm150758.htm (accessed 19 June 2011) 2006"},{"key":"10.1002\/14651858.CD002744.pub3-BIB93|cit93","unstructured":"US Food Drug Administration Relenza prescribing information http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/021036s017lbl.pdf"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub3-BIB94|cit94","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJM197803162981103","article-title":"Interpandemic influenza in the Houston area, 1974-76","volume":"298","author":"Glezen","year":"1978","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002744.pub3-BIB95|cit95","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0531-5131(01)00358-2","article-title":"Influenza virus neuraminidase inhibitors: clinical aspects","volume":"1219","author":"Hayden","year":"2001","journal-title":"International Congress Series"},{"key":"10.1002\/14651858.CD002744.pub3-BIB96|cit96","article-title":"Chapter 8: \u00a0Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011"},{"issue":"1","key":"10.1002\/14651858.CD002744.pub3-BIB97|cit97","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.MR000011.pub2","article-title":"Time to publication for results of clinical trials","author":"Hopewell","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002744.pub3-BIB98|cit98","unstructured":"Health Protection Agency HPA weekly national influenza report 01 July 2009 (Week 27) http:\/\/www.hpa.org.uk\/web\/HPAwebFile\/HPAweb_C\/1246433639498 (accessed 31 May 2011) 2009"},{"key":"10.1002\/14651858.CD002744.pub3-BIB99|cit99","unstructured":"Husereau DR Brady B McGeer A Oseltamivir for the treatment of suspected influenza: a clinical and economic assessment. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 2001 Technology Report No. 21 (available from http:\/\/www.ccohta.ca\/) 2001"},{"issue":"4","key":"10.1002\/14651858.CD002744.pub3-BIB100|cit100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJM200001273420402","article-title":"Influenza and the rates of hospitalization for respiratory disease amongst infants and young children","volume":"342","author":"Izurieta","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002744.pub3-BIB101|cit101","article-title":"Amantadine and rimantadine for influenza A in adults","author":"Jefferson","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"339","key":"10.1002\/14651858.CD002744.pub3-BIB102|cit102","doi-asserted-by":"crossref","first-page":"b3675","DOI":"10.1136\/bmj.b3675","article-title":"Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review","volume":"21","author":"Jefferson","year":"2009","journal-title":"BMJ"},{"issue":"12","key":"10.1002\/14651858.CD002744.pub3-BIB103|cit103","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008965","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children","author":"Jefferson","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002744.pub3-BIB104|cit104","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archinte.161.2.212","article-title":"Zanamivir for the treatment of influenza A and B infection in high-risk patients","volume":"161","author":"Lalezari","year":"2001","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD002744.pub3-BIB105|cit105","article-title":"Chapter 6: Searching for studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org","author":"Lefebvre","year":"2011"},{"key":"10.1002\/14651858.CD002744.pub3-BIB106|cit106","doi-asserted-by":"crossref","unstructured":"Lindbaek M Which children are in need of antibiotic treatment for acute otitis media? Electronic Letter to British Medical Journal (available from http:\/\/bmj.cin\/cgi\/eletter\/318\/7185\/715#2478) 1999","DOI":"10.1136\/bmj.318.7185.715"},{"issue":"5","key":"10.1002\/14651858.CD002744.pub3-BIB107|cit107","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/oxfordjournals.aje.a113356","article-title":"Estimating household and community transmission parameters for influenza","volume":"115","author":"Longini","year":"1982","journal-title":"American Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD002744.pub3-BIB108|cit108","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002744.pub2","article-title":"Neuraminidase inhibitors for preventing and treating influenza in children","author":"Matheson","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002744.pub3-BIB109|cit109","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s100960000376","article-title":"Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom","volume":"19","author":"Meier","year":"2000","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1002\/14651858.CD002744.pub3-BIB110|cit110","unstructured":"MHRA MHRA Drug Safety Update. Safety information on oseltamivir (Tamiflu) and zanamivir (Relenza) for pandemic swine influenza A\/H1N1 http:\/\/www.mhra.gov.uk\/home\/groups\/pl-p\/documents\/publication\/con054506.pdf"},{"key":"10.1002\/14651858.CD002744.pub3-BIB111|cit111","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2296-12-4","article-title":"Clinical prediction rules combining signs, symptoms and epidemiological context to distinguish influenza from influenza-like illnesses in primary care: across sectional study","volume":"12","author":"Michiels","year":"2011","journal-title":"BMC Family Practice"},{"issue":"13","key":"10.1002\/14651858.CD002744.pub3-BIB112|cit112","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD002744.pub3-BIB113|cit113","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00044011-200020050-00005","article-title":"Efficacy and safety of inhaled zanamivir for the treatment of influenza in patients with asthma or chronic obstructive pulmonary disease","volume":"20","author":"Murphy","year":"2000","journal-title":"Clinical Drug Investigation"},{"issue":"2","key":"10.1002\/14651858.CD002744.pub3-BIB114|cit114","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1086\/338363","article-title":"Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study","volume":"185","author":"Neuzil","year":"2002","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD002744.pub3-BIB115|cit115","volume-title":"Amantadine, oseltamivir, and zanamivir for the treatment of influenza","year":"2009"},{"issue":"1","key":"10.1002\/14651858.CD002744.pub3-BIB116|cit116","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0011-393X(00)88495-7","article-title":"Pharmacokinetics and tolerability of a single inhaled dose of zanamivir in children","volume":"61","author":"Peng","year":"2000","journal-title":"Current Therapeutic Research"},{"issue":"4","key":"10.1002\/14651858.CD002744.pub3-BIB117|cit117","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jemermed.2009.11.031","article-title":"Rapid diagnostic testing for seasonal influenza: an evidence based review and comparison with unaided clinical diagnosis","volume":"39","author":"Petrozzino","year":"2010","journal-title":"Journal of Emergency Medicine"},{"key":"10.1002\/14651858.CD002744.pub3-BIB118|cit118","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa054869","article-title":"New Vaccine Surveillance Network. The under recognized burden of influenza in young children","volume":"355","author":"Poehling","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002744.pub3-BIB119|cit119","unstructured":"The Nordic Cochrane Centre. The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub3-BIB120|cit120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00006454-200203000-00006","article-title":"Evaluation of diagnostic tests for influenza in a pediatric practice","volume":"21","author":"Rodriguez","year":"2002","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"4","key":"10.1002\/14651858.CD002744.pub3-BIB121|cit121","first-page":"256","article-title":"Presentation with influenza-like illness in general practice: implications for use of neuraminidase inhibitors","volume":"3","author":"Ross","year":"2000","journal-title":"Communicable Disease and Public Health"},{"key":"10.1002\/14651858.CD002744.pub3-BIB122|cit122","doi-asserted-by":"crossref","first-page":"b3172","DOI":"10.1136\/bmj.b3172","article-title":"Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials","volume":"339","author":"Shun-Shin","year":"2009","journal-title":"BMJ"},{"issue":"7433","key":"10.1002\/14651858.CD002744.pub3-BIB123|cit123","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/bmj.328.7433.227","article-title":"Guidelines on neuraminidase inhibitors in children are not supported by evidence","volume":"328","author":"Symmonds","year":"2004","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD002744.pub3-BIB124|cit124","first-page":"1","article-title":"Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation","volume":"13","author":"Tappenden","year":"2009","journal-title":"Health Technology Assessments"},{"key":"10.1002\/14651858.CD002744.pub3-BIB125|cit125","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2334-11-134","article-title":"Systematic review of influenza resistance to the neuraminidase inhibitors","volume":"11","author":"Thorlund","year":"2011","journal-title":"BMC Infectious Diseases"},{"key":"10.1002\/14651858.CD002744.pub3-BIB126|cit126","doi-asserted-by":"crossref","unstructured":"Turner D Wailoo A Nicholson K Cooper N Sutton A Abrams K Systematic review and economic decision modelling for the prevention and treatment of influenza A and B Health Technology Assessment (available from http:\/\/www.nice.org.uk\/docref.asp?d=35650) 2002","DOI":"10.3310\/hta7350"},{"key":"10.1002\/14651858.CD002744.pub3-BIB127|cit127","unstructured":"World Health Organization Influenza A (H1N1) virus resistance to oseltamivir - 2008\/2009 influenza season, northern hemisphere http:\/\/www.who.int\/csr\/disease\/influenza\/H1N1webupdate20090318%20ed_ns.pdf (accessed 31 May 2011) 2009"},{"issue":"9","key":"10.1002\/14651858.CD002744.pub3-BIB128|cit128","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJM200003023420914","article-title":"Respiratory distress associated with zanamivir","volume":"342","author":"Williamson","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002744.pub3-BIB129|cit129","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/AAC.00333-08","article-title":"CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity","volume":"53","author":"Yamashita","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD002744.pub3-BIB130|cit130","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/S0140-6736(01)06528-X","article-title":"Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study","volume":"358","author":"Zambon","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub3-BIB131|cit131","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0166-3542(01)00124-3","article-title":"Position statement: global neuraminidase inhibitor susceptibility network","volume":"49","author":"Zambon","year":"2001","journal-title":"Antiviral Research"},{"issue":"3","key":"10.1002\/14651858.CD002744.pub3-BIB132|cit132","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002744","article-title":"Neuraminidase inhibitors for preventing and treating influenza in children","author":"Matheson","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD002744.pub3-BIB133|cit133","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002744.pub2","article-title":"Neuraminidase inhibitors for preventing and treating influenza in children","author":"Matheson","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd002744.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T00:00:00Z","timestamp":1334707200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD002744.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T15:16:23Z","timestamp":1686669383000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002744.pub3"}},"subtitle":[],"editor":[{"given":"Anthony","family":"Harnden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,1,18]]},"references-count":133,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002744.pub3","relation":{},"subject":[],"published":{"date-parts":[[2012,1,18]]}}}